Dr. Desiree NW Neville, MD
Claim this profileStudies Arthritis
Studies Rheumatoid Arthritis
1 reported clinical trial
2 drugs studied
More about Desiree NW Neville, MD
Clinical Trial Related6 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Desiree NW Neville, MD has experience with
- Acetaminophen
- Naproxen
Breakdown of trials Desiree NW Neville, MD has run
Arthritis
Rheumatoid Arthritis
Lyme Disease
Lyme disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Desiree NW Neville, MD specialize in?
Desiree NW Neville, MD focuses on Arthritis and Rheumatoid Arthritis. In particular, much of their work with Arthritis has involved treating patients, or patients who are undergoing treatment.
Is Desiree NW Neville, MD currently recruiting for clinical trials?
No, Desiree NW Neville, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Desiree NW Neville, MD has studied deeply?
Yes, Desiree NW Neville, MD has studied treatments such as Acetaminophen, Naproxen.
What is the best way to schedule an appointment with Desiree NW Neville, MD?
Apply for one of the trials that Desiree NW Neville, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.